150 related articles for article (PubMed ID: 22404639)
1. Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
Beloncle F; Buffet M; Coindre JP; Munoz-Bongrand N; Malot S; Pène F; Mira JP; Galicier L; Guidet B; Baudel JL; Subra JF; Tanguy-Schmidt A; Pourrat J; Azoulay E; Veyradier A; Coppo P;
Transfusion; 2012 Nov; 52(11):2436-44. PubMed ID: 22404639
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
Froissart A; Buffet M; Veyradier A; Poullin P; Provôt F; Malot S; Schwarzinger M; Galicier L; Vanhille P; Vernant JP; Bordessoule D; Guidet B; Azoulay E; Mariotte E; Rondeau E; Mira JP; Wynckel A; Clabault K; Choukroun G; Presne C; Pourrat J; Hamidou M; Coppo P;
Crit Care Med; 2012 Jan; 40(1):104-11. PubMed ID: 21926591
[TBL] [Abstract][Full Text] [Related]
3. Splenectomy for the treatment of thrombotic thrombocytopenic purpura.
Kappers-Klunne MC; Wijermans P; Fijnheer R; Croockewit AJ; van der Holt B; de Wolf JT; Löwenberg B; Brand A
Br J Haematol; 2005 Sep; 130(5):768-76. PubMed ID: 16115135
[TBL] [Abstract][Full Text] [Related]
4. Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura.
Aqui NA; Stein SH; Konkle BA; Abrams CS; Strobl FJ
J Clin Apher; 2003; 18(2):51-4. PubMed ID: 12874815
[TBL] [Abstract][Full Text] [Related]
5. Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
Soucemarianadin M; Benhamou Y; Delmas Y; Pichereau C; Maury E; Pène F; Halimi JM; Presne C; Thouret JM; Veyradier A; Coppo P
Eur J Haematol; 2016 Aug; 97(2):183-91. PubMed ID: 26608617
[TBL] [Abstract][Full Text] [Related]
6. Outcomes in the treatment of thrombotic thrombocytopenic purpura with splenectomy: a retrospective cohort study.
Outschoorn UM; Ferber A
Am J Hematol; 2006 Dec; 81(12):895-900. PubMed ID: 16888787
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura.
Reddy PS; Deauna-Limayo D; Cook JD; Ganguly SS; Blecke C; Bodensteiner DC; Skikne BS; Sahud MA
Ann Hematol; 2005 Apr; 84(4):232-5. PubMed ID: 15517266
[TBL] [Abstract][Full Text] [Related]
8. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of rituximab therapy for refractory/relapsing thrombotic thrombocytopenic purpura].
Cui J; Zhu TN; Zou N; Chen M; Zhao YQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):116-20. PubMed ID: 23469801
[TBL] [Abstract][Full Text] [Related]
10. Management of thrombotic thrombocytopenic purpura.
Coppo P;
Transfus Clin Biol; 2017 Sep; 24(3):148-153. PubMed ID: 28645643
[TBL] [Abstract][Full Text] [Related]
11. Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange.
Coppo P; Froissart A;
Hematology Am Soc Hematol Educ Program; 2015; 2015():637-43. PubMed ID: 26637782
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab.
Chemnitz J; Draube A; Scheid C; Staib P; Schulz A; Diehl V; Söhngen D
Am J Hematol; 2002 Oct; 71(2):105-8. PubMed ID: 12353309
[TBL] [Abstract][Full Text] [Related]
13. Outcome and relapse risks of thrombotic thrombocytopaenic purpura: an Egyptian experience.
El-Husseiny NM; Goubran H; Fahmy HM; Tawfik NM; Moustafa H; Amin SN; El-Ekiaby M
Postgrad Med J; 2012 Aug; 88(1042):433-6. PubMed ID: 22434913
[TBL] [Abstract][Full Text] [Related]
14. Treatment of autoimmune thrombotic thrombocytopenic purpura in the more severe forms.
Coppo P;
Transfus Apher Sci; 2017 Feb; 56(1):52-56. PubMed ID: 28110841
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Hayward CP; Sutton DM; Carter WH; Campbell ED; Scott JG; Francombe WH; Shumak KH; Baker MA
Arch Intern Med; 1994 May; 154(9):982-7. PubMed ID: 8179455
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic plasma exchange plus corticosteroid for the treatment of the thrombotic thrombocytopenic purpura: a single institutional experience in the southern Marmara region of Turkey.
Ozkalemkas F; Ali R; Ozkocaman V; Ozcelik T; Ozkan A; Tunali A
Transfus Apher Sci; 2007 Feb; 36(1):109-15. PubMed ID: 17291831
[TBL] [Abstract][Full Text] [Related]
17. Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institution.
Onundarson PT; Rowe JM; Heal JM; Francis CW
Arch Intern Med; 1992 Apr; 152(4):791-6. PubMed ID: 1558437
[TBL] [Abstract][Full Text] [Related]
18. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
[TBL] [Abstract][Full Text] [Related]
19. Recovery by splenectomy in patients with relapsed thrombotic thrombocytopenic purpura and treatment failure to plasma exchange.
Höffkes HG; Weber F; Uppenkamp M; Meusers P; Teschendorf C; Philipp T; Brittinger G
Semin Thromb Hemost; 1995; 21(2):161-5. PubMed ID: 7660138
[TBL] [Abstract][Full Text] [Related]
20. A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus.
Letchumanan P; Ng HJ; Lee LH; Thumboo J
Rheumatology (Oxford); 2009 Apr; 48(4):399-403. PubMed ID: 19202160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
